Literature DB >> 31814304

Integrated analysis of exosomal lncRNA and mRNA expression profiles reveals the involvement of lnc-MKRN2-42:1 in the pathogenesis of Parkinson's disease.

Qiao Wang1,2, Chun-Lei Han1,2, Kai-Liang Wang1,2, Yun-Peng Sui1,2, Zhi-Bao Li1,2, Ning Chen3, Shi-Ying Fan1,2, Michitomo Shimabukuro1,2, Feng Wang4, Fan-Gang Meng1,2,3.   

Abstract

BACKGROUND: Parkinson's disease (PD) is a common movement disorder for which diagnosis mainly depends on the medical history and clinical symptoms. Exosomes are now considered an additional mechanism for intercellular communication, allowing cells to exchange proteins, lipids, and genetic material. Long noncoding (lnc) RNA in exosomes plays a critical role in many diseases, including neurodegenerative disease. AIM: To study expression differences for lncRNAs in peripheral blood exosomes of PD patients compared with healthy individuals and to look for lncRNAs that might be related to the pathogenesis of PD.
MATERIALS AND METHODS: We recruited PD patients along with age- and sex-matched healthy individuals as healthy controls and evaluated levels of lncRNAs extracted from exosomes in plasma samples via next-generation sequencing and real-time quantitative PCR. Correlation analysis was conducted for the clinical characteristics of PD patients and the expression of selected lncRNAs.
RESULTS: We found 15 upregulated and 24 downregulated exosomal lncRNAs in the PD group. According to bioinformatics analyses, we chose lnc-MKRN2-42:1 for further study. Interestingly, lnc-MKRN2-42:1 was positively correlated with the MDS-UPDRS III score for PD patients.
CONCLUSION: Our study suggested that lnc-MKRN2-42:1 may be involved in the occurrence and development of PD.
© 2019 The Authors. CNS Neuroscience & Therapeutics published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Lnc-MKRN2-42:1; MDS-UPDRS III; Parkinson's disease; exosome; next-generation sequencing

Year:  2019        PMID: 31814304     DOI: 10.1111/cns.13277

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  18 in total

Review 1.  Long Non-coding RNAs in Parkinson's Disease.

Authors:  Chengqi Xin; Jing Liu
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

2.  Bioinformatics-Based Analysis of the lncRNA-miRNA-mRNA Network and TF Regulatory Network to Explore the Regulation Mechanism in Spinal Cord Ischemia/Reperfusion Injury.

Authors:  Dan Wang; Limei Wang; Jie Han; Zaili Zhang; Bo Fang; Fengshou Chen
Journal:  Front Genet       Date:  2021-04-27       Impact factor: 4.599

Review 3.  Role of Long Noncoding RNAs in Parkinson's Disease: Putative Biomarkers and Therapeutic Targets.

Authors:  Qiankun Lv; Ziyu Wang; Zhen Zhong; Wei Huang
Journal:  Parkinsons Dis       Date:  2020-06-12

4.  Genome-Scale Expression Pattern of Long Non-Coding RNAs in Chinese Uyghur Patients with Parkinson's Disease.

Authors:  Dan Wang; Hua Gao; Yanxia Li; Sen Jiang; Yuxuan Yong; Xinling Yang
Journal:  Med Sci Monit       Date:  2020-10-08

Review 5.  Recent Advances on Extracellular Vesicles in Central Nervous System Diseases.

Authors:  Tao Jin; Jiachen Gu; Zongshan Li; Zhongping Xu; Yaxing Gui
Journal:  Clin Interv Aging       Date:  2021-02-10       Impact factor: 4.458

Review 6.  Roles and mechanisms of exosomal non-coding RNAs in human health and diseases.

Authors:  Chen Li; Yu-Qing Ni; Hui Xu; Qun-Yan Xiang; Yan Zhao; Jun-Kun Zhan; Jie-Yu He; Shuang Li; You-Shuo Liu
Journal:  Signal Transduct Target Ther       Date:  2021-11-10

Review 7.  Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review.

Authors:  Jian Wang; Bing-Lin Yue; Yong-Zhen Huang; Xian-Yong Lan; Wu-Jun Liu; Hong Chen
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

8.  Long non‑coding RNA expression profiles identify lncRNA‑XLOC_I2_006631 as a potential novel blood biomarker for Hashimoto's thyroiditis.

Authors:  Huiyong Peng; Si Xiong; Xiangmei Ding; Xinyi Tang; Xuehua Wang; Li Wang; Yingzhao Liu
Journal:  Int J Mol Med       Date:  2020-10-13       Impact factor: 4.101

9.  Circulating exosomal miR-363-5p inhibits lymph node metastasis by downregulating PDGFB and serves as a potential noninvasive biomarker for breast cancer.

Authors:  Xin Wang; Tianyi Qian; Siqi Bao; Hengqiang Zhao; Hongyan Chen; Zeyu Xing; Yalun Li; Menglu Zhang; Xiangzhi Meng; Changchang Wang; Jie Wang; Hongxia Gao; Jiaqi Liu; Meng Zhou; Xiang Wang
Journal:  Mol Oncol       Date:  2021-06-25       Impact factor: 6.603

Review 10.  Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.

Authors:  Ida Manna; Andrea Quattrone; Selene De Benedittis; Enrico Iaccino; Aldo Quattrone
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.